TRANSCAN-3

TRANSCAN-3: Sustained collaboration of national and regional programs in cancer research

The ERA-NET TRANSCAN-3 (2021-2026) is a Cofunded ERA-NET in translational cancer research, being the third TRANSCAN initiative in which FCT is a partner. This network now has 31 partners from 20 countries. This ERA-NET aims to coordinate national/regional funding programs in the area of translational cancer research. The specific challenge is to promote a collaborative transnational approach between scientific teams in challenging areas of translational cancer research.

This initiative will receive funding from Horizon 2020 under Grant Agreement No. 964264.